119 related articles for article (PubMed ID: 36848082)
1. Stat3 role in the protective effect of FXR Agonist in parenteral nutrition-associated cholestasis.
Ghosh S; Devereaux MW; Anderson AL; El Kasmi KC; Sokol RJ
Hepatol Commun; 2023 Mar; 7(3):e0056. PubMed ID: 36848082
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic activation of hepatic farnesoid X receptor prevents parenteral nutrition-associated cholestasis in mice.
El Kasmi KC; Ghosh S; Anderson AL; Devereaux MW; Balasubramaniyan N; D'Alessandro A; Orlicky DJ; Suchy FJ; Shearn CT; Sokol RJ
Hepatology; 2022 Feb; 75(2):252-265. PubMed ID: 34387888
[TBL] [Abstract][Full Text] [Related]
3. NF-κB Regulation of LRH-1 and ABCG5/8 Potentiates Phytosterol Role in the Pathogenesis of Parenteral Nutrition-Associated Cholestasis.
Ghosh S; Devereaux MW; Anderson AL; Gehrke S; Reisz JA; D'Alessandro A; Orlicky DJ; Lovell M; El Kasmi KC; Shearn CT; Sokol RJ
Hepatology; 2021 Dec; 74(6):3284-3300. PubMed ID: 34310734
[TBL] [Abstract][Full Text] [Related]
4. LRH-1 agonist DLPC through STAT6 promotes macrophage polarization and prevents parenteral nutrition-associated cholestasis in mice.
Ghosh S; Devereaux MW; Liu C; Sokol RJ
Hepatology; 2024 May; 79(5):986-1004. PubMed ID: 37976384
[TBL] [Abstract][Full Text] [Related]
5. Macrophage-derived IL-1β/NF-κB signaling mediates parenteral nutrition-associated cholestasis.
El Kasmi KC; Vue PM; Anderson AL; Devereaux MW; Ghosh S; Balasubramaniyan N; Fillon SA; Dahrenmoeller C; Allawzi A; Woods C; McKenna S; Wright CJ; Johnson L; D'Alessandro A; Reisz JA; Nozik-Grayck E; Suchy FJ; Sokol RJ
Nat Commun; 2018 Apr; 9(1):1393. PubMed ID: 29643332
[TBL] [Abstract][Full Text] [Related]
6. Interrupting tumor necrosis factor-alpha signaling prevents parenteral nutrition-associated cholestasis in mice.
El Kasmi KC; Anderson AL; Devereaux MW; Balasubramaniyan N; Suchy FJ; Orlicky DJ; Shearn CT; Sokol RJ
JPEN J Parenter Enteral Nutr; 2022 Jul; 46(5):1096-1106. PubMed ID: 34664730
[TBL] [Abstract][Full Text] [Related]
7. Relevance of FXR-p62/SQSTM1 pathway for survival and protection of mouse hepatocytes and liver, especially with steatosis.
Haga S; Yimin ; Ozaki M
BMC Gastroenterol; 2017 Jan; 17(1):9. PubMed ID: 28086800
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic inhibition of HNF4α prevents parenteral nutrition associated cholestasis in mice.
Ghosh S; Devereaux MW; Orlicky DJ; Sokol RJ
Sci Rep; 2023 May; 13(1):7752. PubMed ID: 37173326
[TBL] [Abstract][Full Text] [Related]
9. Expression of circadian regulatory genes is dysregulated by increased cytokine production in mice subjected to concomitant intestinal injury and parenteral nutrition.
Shearn CT; Anderson AL; Devereaux MW; El Kasmi KC; Orlicky DJ; Sokol RJ
PLoS One; 2023; 18(8):e0290385. PubMed ID: 37647292
[TBL] [Abstract][Full Text] [Related]
10. Nerve growth factor induced farnesoid X receptor upregulation modulates autophagy flux and protects hepatocytes in cholestatic livers.
Tsai MS; Lee HM; Huang SC; Sun CK; Chiu TC; Chen PH; Lin YC; Hung TM; Lee PH; Kao YH
Arch Biochem Biophys; 2020 Mar; 682():108281. PubMed ID: 32001246
[TBL] [Abstract][Full Text] [Related]
11. Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor.
Li T; Xu L; Zheng R; Wang X; Li L; Ji H; Hu Q
Phytomedicine; 2020 Mar; 68():153153. PubMed ID: 32018210
[TBL] [Abstract][Full Text] [Related]
12. The FXR Agonist, Obeticholic Acid, Suppresses HCC Proliferation & Metastasis: Role of IL-6/STAT3 Signalling Pathway.
Attia YM; Tawfiq RA; Ali AA; Elmazar MM
Sci Rep; 2017 Oct; 7(1):12502. PubMed ID: 28970500
[TBL] [Abstract][Full Text] [Related]
13. Farnesoid X Receptor Agonist GW4064 Inhibits Aromatase and ERβ Expression in Human Endometriotic Stromal Cells.
Wu PL; Zeng C; Zhou YF; Yin L; Yu XL; Xue Q
Reprod Sci; 2019 Aug; 26(8):1111-1120. PubMed ID: 30428773
[TBL] [Abstract][Full Text] [Related]
14. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis.
Liu Y; Binz J; Numerick MJ; Dennis S; Luo G; Desai B; MacKenzie KI; Mansfield TA; Kliewer SA; Goodwin B; Jones SA
J Clin Invest; 2003 Dec; 112(11):1678-87. PubMed ID: 14623915
[TBL] [Abstract][Full Text] [Related]
15. Effects of corilagin on alleviating cholestasis via farnesoid X receptor-associated pathways in vitro and in vivo.
Yang F; Wang Y; Li G; Xue J; Chen ZL; Jin F; Luo L; Zhou X; Ma Q; Cai X; Li HR; Zhao L
Br J Pharmacol; 2018 Mar; 175(5):810-829. PubMed ID: 29235094
[TBL] [Abstract][Full Text] [Related]
16. Farnesoid X receptor signaling activates the hepatic X-box binding protein 1 pathway in vitro and in mice.
Liu X; Guo GL; Kong B; Hilburn DB; Hubchak SC; Park S; LeCuyer B; Hsieh A; Wang L; Fang D; Green RM
Hepatology; 2018 Jul; 68(1):304-316. PubMed ID: 29377207
[TBL] [Abstract][Full Text] [Related]
17. Farnesoid X receptor (FXR) activation induces the antioxidant protein metallothionein 1 expression in mouse liver.
Wang B; Zhang H; Luan Z; Xu H; Wei Y; Zhao X; Xing M; Huo X; Zhang J; Su W; Guan Y; Zhang X
Exp Cell Res; 2020 May; 390(1):111949. PubMed ID: 32145254
[TBL] [Abstract][Full Text] [Related]
18. Restoration of enterohepatic bile acid pathways in pregnant mice following short term activation of Fxr by GW4064.
Moscovitz JE; Kong B; Buckley K; Buckley B; Guo GL; Aleksunes LM
Toxicol Appl Pharmacol; 2016 Nov; 310():60-67. PubMed ID: 27609522
[TBL] [Abstract][Full Text] [Related]
19. Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity.
Yu J; Lo JL; Huang L; Zhao A; Metzger E; Adams A; Meinke PT; Wright SD; Cui J
J Biol Chem; 2002 Aug; 277(35):31441-7. PubMed ID: 12052824
[TBL] [Abstract][Full Text] [Related]
20. Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro.
Gao X; Fu T; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Huo X; Yang X; Zou M; Meng Q
Toxicol Appl Pharmacol; 2018 Jun; 348():105-116. PubMed ID: 29660435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
